UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): May 27, 2010
WRIGHT MEDICAL GROUP, INC.
(Exact name of registrant as specified in charter)
| |
|
|
|
|
|
| Delaware
|
|
000-32883
|
|
13-4088127 |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification Number) |
| |
|
|
|
| 5677 Airline Road, Arlington, Tennessee
|
|
38002 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (901) 867-9971
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01. Other Events.
Settlement Agreement
As previously disclosed in the notes to our financial statements and elsewhere in our SEC reports,
we have been involved with a lawsuit filed by Howmedica Osteonics Corp. (Howmedica), a subsidiary
of Stryker Corporation alleging that we infringed Howmedica’s U.S. Patent No.
5,824,100 related to our ADVANCE® knee product line. The lawsuit sought an order of
infringement, injunctive relief, unspecified damages, and various other costs and relief. We
contended that our products did not infringe the patent and that the patent was invalid and
unenforceable.
On
May 27, 2010, we resolved this matter by entering into a settlement agreement with Howmedica. As
a result of the settlement agreement, we are entitled to continue to sell our ADVANCE® knee product
line without any current or future monetary payments to Howmedica. We had not established a reserve
for the litigation. Therefore, the settlement resulted in no impact to our consolidated financial
position or results of operations.
1